Full Press Release Details
Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715, an Anti-BCMA AlloCAR T Therapy in Multiple Myeloma.
ALLO
Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715, an Anti-BCMA AlloCAR T Therapy in Multiple Myeloma
Key Takeaway: Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715, an Anti-BCMA AlloCAR T Therapy in Multiple Myeloma